Louisiana moves to back psychedelic drug research for mental health, addiction treatment

By: Wesley Muller

Outlets: Louisiana Illuminator

Published: May 18, 2026

Words: 727

Last Updated: 2 months ago

Body Text Preview

The Louisiana Legislature is on the verge of approving state support for clinical studies on psychedelic drugs used to treat mental health and substance abuse disorders.

Senate Bill 43, sponsored by Sen. Patrick McMath, R-Mandeville, would create a state health initiative for studies on ibogaine, psilocybin, MDMA (also known as “Molly”) and other psychedelic drugs once considered to have no medical value and strictly banned. The proposal has received unanimous support from both …

Create a free account to access this story and more

Join Plucky Wire to access full stories, collaborate with newsrooms, and discover content from networks around the world.

About

FAQ

Email Us